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Prokaryotic pentameric ligand-gated ion
channelsMembrane lipids are potent modulators of the nicotinic acetylcholine receptor (nAChR) from Torpedo. Lipids
inﬂuence nAChR function by both conformational selection and kinetic mechanisms, stabilizing varying propor-
tions of activatable versus non-activatable conformations, aswell as inﬂuencing the transitions between these con-
formational states. Of note, some membranes stabilize an electrically silent uncoupled conformation that binds
agonist but does not undergo agonist-induced conformational transitions. The uncoupled nAChR, however, does
transition to activatable conformations in relatively thick lipid bilayers, such as those found in lipid rafts. In this re-
view, we discuss current understanding of lipid–nAChR interactions in the context of increasingly available high
resolution structural and functional data. These data highlight different sites of lipid action, including the lipid-
exposed M4 transmembrane α-helix. Current evidence suggests that lipids alter nAChR function by modulating
interactions between M4 and the adjacent transmembrane α-helices, M1 and M3. These interactions have also
been implicated in both the folding and trafﬁcking of nAChRs to the cell surface. We review current mechanistic
understanding of lipid–nAChR interactions, and highlight potential biological roles for lipid–nAChR interactions
in modulating the synaptic response. This article is part of a Special Issue entitled: Lipid–protein interactions.
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iger).1. Introduction
The nicotinic acetylcholine receptor (nAChR) from Torpedo is the
prototypic member of a broad family of pentameric ligand-gated ion
channels (pLGICs) that are found in pre-, post-, and non-synaptic
1807J.E. Baenziger et al. / Biochimica et Biophysica Acta 1848 (2015) 1806–1817membranes of the central and peripheral nervous systems. These
neurotransmitter receptors perform important roles in both synaptic
communication and information processing, have been implicated in a
variety of neurological processes and diseases, and are targets of numer-
ous pharmaceuticals [1–5].
Early attempts to isolate and reconstitute the Torpedo nAChR in
model membranes ﬁrst highlighted the functional sensitivity of the
nAChR to lipids. To retain agonist-induced channel ﬂux, the nAChR
must be solubilized and puriﬁed in the presence of lipid, and then
placed in a membrane with an appropriate lipid composition [6–9].
The exquisite lipid sensitivity of the Torpedo nAChR is of interest
because even subtle changes in human nAChR activity have profound
effects on human biology [10,11]. In addition, the lipid environment of
the human nAChR changes as the nAChR trafﬁcs from intracellular
membranes to its pre-, post-, or non-synaptic locations in the plasma
membrane, aswell as during both aging and neurodegenerative disease
[12–14]. These changes in the nAChR lipid micro-environment during
both normal and abnormal brain functions likely inﬂuence cholinergic
biology to alter synaptic communication.
The relative abundance of the nAChR in the electric ﬁsh Torpedo
has made it the ideal model for studies of ligand-gated ion channel
structure/function relationships. Biophysical and biochemical
studies over the past three decades have led to an extensive litera-
ture on lipid–nAChR interactions, which has been summarized in
several comprehensive reviews [15–19]. In the past decade, a 4 Å
resolution cryo-electron microscopy model of the Torpedo nAChR
(Fig. 1) [20], as well as X-ray crystal structures of homologous
pLGICs [21–29] and water-soluble homologs of the nAChR extra-
membranous agonist-binding domain [30,31], and NMR structures
of nAChR transmembrane domains [32,33] have provided an
increasingly detailed picture of both nAChR structure and the
nature of ligand-induced conformational change. With this struc-
tural data in hand, we are now in an unprecedented position to
probe the mechanisms underlying lipid–nAChR interactions at a
structural/mechanistic level.
This review focuses on our current understanding of lipid–nAChR
interactions in the context of these recently solved pLGIC structures.
We review the structural properties of the Torpedo nAChR, the Torpedo
nAChR's lipid requirements, and currentmodels of lipid–nAChR interac-
tions. We also highlight potential roles for lipids in the folding,
cell-surface trafﬁcking, and domain localization of the nAChRs in
mammalian tissues.Fig. 1. Structure of the A) nAChR, B)GLIC, and C) ELIC. A) A side viewof the Torpedo nAChR struc
transmembrane domain (TMD) in blue, and the cytoplasmic domain (CD) in green. Residues co
theβ,γ, and δ subunits) are shown as yellow spheres. The agonist binding siteαTrp149 is shown
of the GLIC structure (PDB ID: 3EAM) with coloring as in A). Residues contributing to the propo
structure (PDB ID: 2VL0)with coloring as inA). Residues contributing to theproposed channel g
cyan spheres.2. nAChR structure
There are seventeen homologous nAChR subunits in mammals
(α1–α10, β1–β4, γ, ε, and δ) that combine to form a variety of either
homo-pentameric or hetero-pentameric structures [34]. The Torpedo
nAChR is most similar to the muscle-type nAChR found at the neuro-
muscular junction, being formed from four distinct subunit types orga-
nized in an (α1)2β1γδ pentamer. In the adult muscle, the fetal
γ-subunit of the (α1)2β1γδ pentamer is replaced by the ε-subunit.
nAChRs are also an important part of the central nervous system, with
both heteromericα4β2 and homomericα7 nAChRs abundant through-
out the human brain, and less abundant combinations, such as α3β4,
α3β2, and α6β2β3 nAChRs, targeted to speciﬁc brain regions [1,2].
The ﬁve subunits of the Torpedo nAChR pentamer are arranged
pseudo-symmetrically around a central axis that functions as an ion
channel (Fig. 1A) [20]. Each subunit contributes three distinct domains,
a roughly 200-residue long N-terminal extracellular domain (ECD)
responsible for agonist binding, a roughly 150-residue long transmem-
brane domain (TMD) responsible for ion channel conductance, and a
cytoplasmic domain of variable length that links to the cytoskeleton.
The ECD of each subunit consists of 10 β-strands (β1–β10) forming
two β-sheets that fold into a classic β-sandwich. Theα-subunit contrib-
utes the principal face of each agonist site [35], with the complementary
face formed by the adjacent γ- and δ-subunits [36,37]. The TMD of each
subunit contributes four transmembraneα-helices (M1–M4) organized
in a four-helix bundle. The ﬁve M2 α-helices line the channel pore,
while M1 andM3 from each subunit form a ring ofα-helices that shield
M2 from themembrane [20,38,39]. TheM4α-helices are located on the
periphery of each subunit where they are exposed to the lipid bilayer.
The cytoplasmic domain of each subunit contributes an α-helix that
extends away from the membrane surface. The cytoplasmic domain is
located in a long loop positioned between transmembrane α-helices
M3 and M4.
Communication between the ECD and TMD in each subunit is medi-
ated primarily by the covalent link between the C-terminus of β10 in
the ECD and the N-terminus of M1 in the TMD, as well as by non-
covalent connections between the β1/β2 and β6/β7 loops (the latter
is referred to as the Cys-loop in eukaryotic pLGICs) of the ECD and the
M2–M3 linker of the TMD (Fig. 2) [40,41]. Although the detailed struc-
tural changes that occur when agonist binding couples to channel
gating remain controversial, it is thought that concerted movements
of the two β-sheets in the ECD lead to changes in structure of both theture (PDB ID: 2BG9) is shown on the leftwith the agonist-binding domain (ABD) in red, the
ntributing to the proposed channel gate (αLeu251, αVal255 and homologous residues in
as cyan spheres. Topdownviews of the ECD and TMDare shownon the right. B) Side view
sed channel gate (I233, I240, L241) are shown as yellow spheres. C) Side view of the ELIC
ate (L239 and F246) are shown as yellow spheres. The agonist binding site F187 is shown as
Fig. 2. Conformations ofM4 at the ECD/TMD interface of the nAChR, GLIC and ELIC. Structures are for the A) nAChR (PDB ID: 2BG9), B) GLIC (PDB ID: 3EAM), and C) ELIC (PDB ID: 2VL0). In
each case, post-M4, the β1–β2 loop, the β6–β7 loop (Cys-loop), and theM2–M3 linker are highlighted in orange, light blue, green, and red, respectively. For the nAChR, direct interactions
between post-M4 (Gln435) and the Cys-loop (Phe137) are circled. For GLIC, a lipid molecule (beige space ﬁlling model) bridges interactions between post-M4 (Phe315) and the β6–β7
loop (Phe121).
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movement of the pore-lining M2 α-helices via direct interactions with
the M2–M3 linker [22–24,41–44]. In the closed resting conformation,
the ion channel is occluded by hydrophobic residues located near the
center of the bilayer that provide a barrier to the ﬂow of a solvated ion
(Fig. 1) [45]. Upon gating to the open state, a proposed twisting and
tilting of the M2 α-helices widen the pore by ~3 Å, allowing the ﬂow
of solvated ions down their electrochemical gradient. Prolonged expo-
sure to agonist leads to the formation of one or more poorly-deﬁned
channel inactive desensitized conformations, which are characterized
by a relatively high afﬁnity for agonist [46].
3. Lipid-dependent modulation of nAChR function
3.1. The nAChR's lipid requirements
Studies in the 1980s established that the ability of the Torpedo
nAChR to both undergo agonist-induced state transitions and ﬂux
cations across the membrane depends on the nAChR's surrounding
lipid environment [8,9,47–49]. Although a variety of lipids and
membrane properties were found to inﬂuence the nAChR, both cho-
lesterol and anionic lipids quickly emerged as being critical for chan-
nel function. The role of cholesterol in promoting nAChR function is
not surprising given that cholesterol is a major component of nativeTorpedo membranes (~35 mol%). Anionic lipids are also common
(~15 mol%), with phosphatidylserine (PS) being the dominant an-
ionic lipid (~10 mol%) and phosphatidylinositol (PI), phosphatidic
acid (PA), and cardiolipin found in lesser amounts [50]. The lipid re-
quirements of the nAChR in reconstituted membranes thus reﬂect
the natural lipid composition of Torpedo membranes.
Many of the original assays designed to survey lipid requirements,
however, simply probed whether the inclusion of a particular lipid in
a PC membrane stabilized a measurable pool of functional nAChRs. As
these assays could not accurately quantify the relative proportions of
activatable versus non-activatable conformations, membranes were
typically characterized as either supporting channel function or stabiliz-
ing a non-functional nAChR. For example, PC membranes containing
cholesterol and an anionic lipid at a 3:1:1molar ratio were found to sta-
bilize a large pool of agonist-responsive nAChRs, while 3:1 molar ratios
of PC/cholesterol, PC/PS, PC/PA, or PC alone did not [8]. Subsequent
studies revealed that lipids inﬂuence nAChR function primarily via a
conformational selection mechanism, modulating the equilibria be-
tween functional and non-functional conformations (see Section 3.3)
[51,52]. Increasing levels of either cholesterol or PA alone in a PC mem-
brane were found to stabilize an increasing proportion of agonist-
activatable resting state nAChRs, with even low dosages of either lipid
having measurable effects [52]. Even though the levels of cholesterol
or PA in a PC membrane that are required to optimally support nAChR
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ﬁndings suggest that neither cholesterol nor anionic lipids are absolute-
ly essential for the nAChR to undergo agonist-induced state transitions.
The lack of a speciﬁc requirement for cholesterol is supported
further by the observation that several cholesterol analogs and other
neutral lipids, such as diacylglycerol, effectively replace cholesterol in
PC/anionic lipid bilayers to support channel function [53,54]. On the
other hand, while anionic lipids are broadly effective at promoting
agonist-induced ﬂux in the presence of PC and cholesterol [53], distinct
efﬁcacies emerge in the absence of cholesterol. Binary mixtures of PC
and PA stabilize a large pool of agonist-responsive nAChRs, while
mixtures of PC and PS stabilize predominantly non-activatable confor-
mations [55,56]. There is clearly more to the effects of anionic lipids
on nAChR function than the net anionic lipid charge.
The observed complexities in lipid–nAChR interactions may stem
from the fact that lipids exert their effects on channel function via
both speciﬁc and non-speciﬁc mechanisms. Cholesterol may bind to
sites within the nAChR TMD (see Section 3.2). It may also inﬂuence
nAChR function by increasing the order of PC bilayers, thus inﬂuencing
other bulkmembrane properties, such as bilayer thickness [15,57]. Bulk
membrane effects would explain the ability of cholesterol analogs and
other neutral lipids to substitute for cholesterol in promoting channel
function, as well as why a cholesterol analog covalently linked to PC,
which presumably resides within the bulk membrane environment, is
as effective as free cholesterol in supporting nAChR function [58].
The distinct efﬁcacies of PA and PS in supporting nAChR function in
the absence of cholesterol can also be rationalized in terms of both
speciﬁc and non-speciﬁc lipid–nAChR interactions. The anionic lipid
charge may be required to promote effective electrostatic interactions
within the nAChR (see, for example [59]), but such interactions may
only be effective when the nAChR is immersed in an appropriate bulk
membrane physical environment— such as that created in the presence
of cholesterol. High levels of the anionic lipid PA in a PCmembranemay
be uniquely effective at stabilizing a functional nAChR because PA has
both an anionic charge and a small head group. Given the small head
group, incorporation of PA into a PC bilayer leads to an ordering of the
membrane and an increase in its gel-to-liquid phase transitions [55],
which may mimic the ordering effects of cholesterol. In contrast, high
levels of PS, which has a larger head group, in a PCmembrane, have little
effect on reconstituted membrane physical properties [56].
The role of bulkmembrane physical properties inmodulatingnAChR
function has been debated in numerous publications, with some studies
concluding that bulkmembrane effects are the keymodulators of chan-
nel function, and others concluding that lipid chemistry, and thus pre-
sumably the binding of lipids to speciﬁc sites on the nAChR, is more
important [8,56,60]. Part of the controversy likely stems from the fact
that membrane physical properties have typically been assessed using
bilayer gel-to-liquid crystal phase transition temperatures and/or either
ﬂuorescent or spin-labeled probes, the latter providing a numerical
measure of membrane order. These bulk membrane parameters may
not be sufﬁciently robust to capture the complex physical environment
of a reconstituted nAChR membrane. It is also difﬁcult to probe the
inﬂuence of bulk membrane properties, such as membrane hydropho-
bic thickness, curvature stress and bilayer ordering, without changing
the bilayer lipid chemistry, complicating the interpretation of the exper-
imental ﬁndings. A recent study, however, showed that while the
nAChR in PC membranes containing di18:1 or shorter acyl chains is
locked in a non-activatable "uncoupled" conformation, the nAChR in
relatively thick PC membranes with di22:1 acyl chains undergoes
agonist-induced conformational transitions, even in the absence of cho-
lesterol or anionic lipids [61]. The latter provides deﬁnitive evidence
that membrane properties inﬂuence agonist-induced state transitions,
and highlights the need for further studies to better understand the
link between the nAChR and its membrane physical environment.
Finally, it should be noted that the lipid requirements of the nAChR
in simple reconstituted membranes may not accurately reﬂect thelipid requirements of the nAChR in natural membrane environments.
Biological membranes are asymmetric with an uneven distribution of
lipids in the two leaﬂets of the lipid bilayer [15]. The possibility that
lipids have different effects on nAChR function when included in differ-
ent leaﬂets has not yet been rigorously tested. As well, natural mem-
branes exhibit lateral separations of lipids into micro-domains/lipid
rafts, with the lipid composition in the microenvironment surrounding
the nAChR not matching the bulk membrane lipid composition. Finally,
an intriguing study showed that the inclusion of only 1.6 mol% PA in a
complex synthetic membrane composed of PC, PS, PI, and cholesterol
has a measurable effect on the proportion of agonist-responsive
nAChRs, while the inclusion of 1.6% PA in a minimal PC membrane
does not [62]. It appears that PA has synergistic effectswith other anion-
ic lipids on nAChR function. These studies collectively show that the
levels of a particular lipid required to measurably inﬂuence nAChR
function in a simple homogeneous reconstituted membrane do not
necessarily match the levels of the same lipid that are required in a
biological membrane to inﬂuence function, where lipid distributions
are heterogeneous and where synergistic effects on function likely
occur. Even trace lipids may have an important role in nAChR function
in biologicalmembranes. The possibility that lipids involved in signaling
inﬂuence nAChR function is obviously of considerable importance,
particularly if signaling lipids are enriched in the nAChR's lipid micro-
environment.
In summary, although many lipids and membrane properties inﬂu-
ence nAChR function, mixtures of both cholesterol and anionic lipids
are particularly effective at stabilizing the nAChR in a functional confor-
mation. Bulk membrane physical properties have an important, yet
poorly understood role. Additional research is still required to elucidate
how a variety of biologically relevant lipids inﬂuence nAChR function,
especially in the context of the complex lipid compositions and hetero-
geneous distributions of lipids that are found in biological membranes.
An important remaining goal is to extrapolate the ﬁndings from studies
of lipid–nAChR interactions in reconstituted nAChR membranes to
biological membranes. Such studies are essential to understanding the
role of lipid–nAChR interactions at the biological synapse.
3.2. Sites of lipid–nAChR interactions
There are likely both annular and non-annular sites of lipid action at
the nAChR [63,64]. Non-annular cholesterol binding sites between
transmembrane α-helices were originally proposed based on ﬂuores-
cence quenching studieswith brominated lipids [64], and are supported
by bothmolecular dynamics simulations and bioinformatics studies [65,
66] (see also [67]). Cholesterol binding to non-annular cavities located
between α-helices within the TMD α-helical bundles stabilizes the
transmembrane domain structure, facilitating interactions with the
ECD [65]. A putative modulatory PC binding site located at the interface
between subunits in the homologous glutamate-activated chloride
channel, GluCl, has also been identiﬁed (Fig. 3A) [28].
Cholesterol and anionic lipids show a strong preference for the
annulus of lipids that surrounds the outer surface of the nAChR
[68–70,147]. At any givenmoment in time, both cholesterol and anionic
lipids in this annulus are “bound” to the nAChR surface, although each
bound lipid exchanges rapidly with others in the bulk membrane envi-
ronment. Annular lipid binding sites have been observed in crystal
structures of the prokaryotic nAChR homolog, GLIC (Fig. 3B) [23]. In
fact, the entire lipid-exposed surface of the nAChR may serve as an
“allosteric site” that is sensitive to bulk membrane physical properties,
such as membrane hydrophobic thickness.
Chemical labeling studies in the early 1990s showed that the M4
transmembrane α-helix forms the predominant interface between the
TMD of each subunit and the lipid environment [71,72]. The location
of M4 at the periphery of the TMD led to the suggestion that M4, in
particular, plays a central role in lipid-sensing [73–75]. In support of
this assertion, a photoactivatable cholesterol analog labels sites on the
Fig. 3.Phospholipids bound to the surface of A)GluCl and B)GLIC. Top panel: GluCl (PDB ID: 4TNW) andGLIC (PDB ID: 3EAM) are shown in amembrane-embedded surface representation,
with one subunit as a blue cartoon diagram and the lipid-exposedM4α-helix in red. Residues contributing to the channel gate are highlighted as yellow spheres. Lipids modeled into the
electron density are presented as tan spheres. Three lipids are bound to each subunit in GLIC. In GluCl, the lipid binding site is at the inter-subunit interface. Bottom panel: top view of the
TMD looking from the extracellular membranous surface.
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on M4 [76,77]. Two of the three lipid binding sites observed in the
crystal structure of GLIC are found at the interfaces between M4
and the adjacent TMD α-helices M1 and M3 (see Section 4.1).
Numerous mutations of M4 lipid-facing residues on both Torpedo
and muscle-type nAChRs, which alter M4–lipid interactions, also
alter channel function [10,78–82], with the amino acid changes
studied to date typically affecting channel opening and closing
rates [81,83,84]. Finally, M4-swapped chimeric constructs of the
homologous glycine receptor α1 and α3 subunits demonstrate that
subunit-speciﬁc agonist efﬁcacy is driven in large part by M4, with
agonist sensitivity mediated by differences in M4–lipid interactions
[85]. M4 thus likely plays a lipid-sensing role in all members of the
broader pLGIC family.3.3. Conformational selection and kinetic mechanisms
To understand the mechanisms underlying lipid–nAChR interac-
tions, research initially focused on elucidating the structural changes
induced in the Torpedo nAChR in the presence of activating lipids.
Although preliminary studies using infrared spectroscopy reported
substantial changes in secondary structure in the presence of cholester-
ol and anionic lipids [86–88], it was subsequently shown that the
observed spectral changes were due instead to distinct levels of peptide
N-1H/N–2H exchange (note that for technical reasons, infrared spectra
are recorded in 2H2O) [89,90]. In fact, the non-functional nAChR in PC
membranes (PC-nAChR) retains a native-like secondary and quaternary
structure [89,91]. PC-nAChR also undergoes thermal denaturation at a
temperature comparable to that of resting and desensitized nAChRs[92,93]. The folded PC-nAChR binds agonist, but lacks the capacity to
undergo agonist-induced conformational change.
Early chemical labeling and infrared difference measurements
suggested that PC-nAChR does not ﬂux cations because it adopts a
desensitized conformation, whereas increasing levels of both
cholesterol and anionic lipids in PC membranes stabilizes an in-
creasing proportion of activatable resting state nAChRs [51,52,62,
94]. These observations led to the hypothesis that membranes
inﬂuence nAChR function by modulating the natural equilibrium
between resting and desensitized conformations, which in native
Torpedo membranes strongly favors the resting state [95,96].
Subsequent studies, however, showed that the non-functional
PC-nAChR does not exhibit the high agonist-binding afﬁnity
characteristic of the desensitized conformation [93,97]. The
conformational selection mechanismwas thus expanded to include
a non-activatable conformation, referred to as the uncoupled state
(Fig. 4) (see Section 3.4). Some membrane environments favor
activatable resting (PC/PA/cholesterol), while others favor
uncoupled (PC alone) and/or desensitized (PC/PS) nAChRs [98].
Lipids also inﬂuence the transitions between conformations.
Increasing membrane hydrophobic thickness lowers the activation
energy barrier between uncoupled and coupled (resting, open, and
desensitized) conformations [61]. Mutations to the lipid facing
surface of M4 inﬂuence both channel opening and closing kinetics.
In effect, lipids/membranes inﬂuence nAChR function by both
conformational selection and kinetic mechanisms. They modify
the magnitude of the agonist-induced response by altering the
relative proportions of resting, desensitized, open, and uncoupled
conformations, as well as the agonist-induced transitions between
each of these states.
CoupledUncoupled
-PA
-Chol
+PA
+Chol
Uncoupled
Coupled
Coupled
(PC)
(PC/PA/Chol)
Uncoupled
Coupled
Thin PC
Membranes
Thick PC
Membranes
(-Carb)
(+Carb)
Uncoupled Uncoupled/
Coupled
Thin PC
Membrane
Thick PC
Membrane
G
Reaction coordinate
G
Reaction coordinate
U
1
R
2
D
O
A
B
Fig. 4. Conformational selection and kinetic mechanisms of lipid–nAChR interactions. A) nAChR function is usually interpreted in terms of a conformational scheme involving resting (R),
open (O), and desensitized (D) conformations (scheme 2). Themembrane-reconstituted Torpedo nAChR can also adopt a non-responsive uncoupled (U) conformation (scheme 1). B) Left
panel: Reaction coordinate diagrams illustrating qualitatively the effects of both lipid composition and membrane bulk properties affect the structure and function of the nAChR. Anionic
lipids and cholesterol inﬂuence the relative proportion of uncoupled versus coupled conformations by interacting preferentially with “coupled” conformations (i.e., conformations where
agonist binding and gating are allosterically coupled), thus lowering their energy relative to uncoupled conformations (a conformational selection mechanism). Membrane thickness inﬂu-
ences the transitions between uncoupled and coupled states by lowering the activation energy between these conformations (a kinetic mechanism). Note that the reaction coordinate
diagrams are qualitative representations. Individual lipids or lipid mixtures may inﬂuence function by a combination of both conformational selection and kinetic mechanisms. Right
panel: Proposed models of uncoupling in the context of conformational selection versus kinetic mechanisms of lipid–nAChR interactions.
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nAChR interactions, one must have intimate knowledge of the struc-
tures of each conformation/transition state, and then elucidate how
each lipid/membrane environment interacts preferentially with
these states to inﬂuence their relative populations, as well as the
transitions between them. While this alone is a complex undertak-
ing, a detailed mechanistic understanding is further confounded by
the aforementioned possibility that lipids inﬂuence function via
both direct and indirect mechanisms. The latter raises the possibility
that a particular lipid could have one effect on channel function, by
preferential binding to one conformation (for example, the resting
state), while at the same time have an opposite effect on channelfunction by changing bulk membrane physical properties to favor
another conformation (for example, a non-activatable desensitized
or uncoupled conformation). Deciphering the mechanisms underly-
ing nAChR–lipid interactions remains a daunting task.
3.4. The uncoupled nAChR
The proposed conformational selection and kineticmechanisms that
underlie lipid–nAChR interactions likely apply to all membrane pro-
teins, with subtle changes in lipid composition/bilayer physical proper-
ties having subtle effects on channel function. As described above, a
unique feature of lipid–nAChR interactions is that a functionally silent,
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reconstituted in PC membranes lacking cholesterol and anionic lipids.
The uncoupled conformation exhibits resting-state-like agonist binding,
but does not ﬂux cations or undergo agonist-induced transitions to the
high afﬁnity agonist-binding desensitized state [98]. The fact that the
uncoupled nAChR still binds agonist, but does not desensitize indicates
that the activation energy barrier between uncoupled and coupled
conformations is insurmountably high over the minute time scale of
most biophysical measurements. This implies that the structural differ-
ences between uncoupled and coupled conformations are energetically
more substantial than those between resting, open, and desensitized
nAChRs [61].
The identiﬁcation of a lipid-dependent uncoupled conformation of
the TorpedonAChRmaybe relevant to human cholinergic biology, as an-
ecdotal evidence suggests that neuronal nAChRs also adopt a function-
ally equivalent conformation. A large proportion of α4β2 nAChRs
expressed on the surface of human embryonic kidney cells bind agonist,
but do not undergo agonist-induced channel gating, consistentwith the
existence of a large pool of uncoupled receptors [99,100]. Some nAChR
subtypes, including those with the α6 subunits, exist in oligomeric
structures on cell surfaces but do not ﬂux cations in response to acetyl-
choline binding [101,102]. In fact, the β3 subunit is essential for the
biogenesis of α6α4β2β3 nAChRs, yet β3 suppresses acetylcholine-
evoked currents. It is possible that the β3 subunit favors formation of
an uncoupled state. The normalized current (current per acetylcholine
binding site on the surface of the cell) also increases with time
after injection of muscle-type cRNA into oocytes, suggesting a time-
dependent maturation in “folding” to activatable conformations [103].
Chronic nicotine exposure upregulates nAChR trafﬁcking to the cell
surface, but there appears to be a role for inactive nAChRs in this process
[104], with chronic nicotine exposure potentially leading to the activa-
tion of previously assembled but inactive nAChRs [105].
As noted, thicker membranes, such as those found in lipid rafts [57,
106], promote slow conformational transitions from uncoupled to
coupled conformations [61]. Neuronal nAChRs require lipid rafts for
trafﬁcking to the cell surface [107,108]. The above observations raise
the intriguing speculation that a lipid raft-dependent transition from
uncoupled to coupled conformations represents a ﬁnal step in the fold-
ing and trafﬁcking of nAChRs to the cell surface, as discussed in more
detail in Section 5.3.5. Structural insight into lipid–nAChR interactions
Both crystallographic and functional studies have increasingly pro-
vided insight into the nature of nAChR structure and conformational
change, opening the door for a more detailed understanding of lipid–
nAChR interactions. Kinetic studies show that the structure of the
lipid-exposed α-helix, M4, is dynamic when the nAChR shifts between
resting and open conformations. When gating, the two αM4 α-helices
in the (α1)2β1εδ pentamer move synchronously, each moving as a
unit roughly halfway along the reaction coordinate between agonist
binding and the open transition state [109]. The motions of the εM4
and βM4 follow that ofαM4,while δM4 has no apparentmotion during
gating. The temporal differences in various M4 positions should permit
the pentamer to present a unique binding surface to the lipid bilayer in
each distinct conformation and/or while transitioning between them.
Movement of M4 has also been suggested in the desensitized state
[110]. Such structural changes inM4 could expose ormask lipid binding
sites, allowing for stronger or weaker interactions with the lipid bilayer
that preferentially stabilize different conformations or promote/inhibit
transitions between these states. In addition, biophysicalmeasurements
and molecular dynamics simulations suggest that the orientation of M4
relative to themembrane normal depends on the presence of cholester-
ol and bilayer thickness [73,74]. Lipids may preferentially stabilize
different orientations of M4 relative to the remainder of the TMD,altering gating kinetics as M4 moves along the reaction coordinate
leading from agonist binding to the open state.
A role has also been proposed for M4 in formation of the lipid-
dependent uncoupled conformation. The uncoupled nAChR undergoes
more extensive peptide N-1H/N–2H exchange than either resting or
desensitized nAChRs. Curve-ﬁtting the peptide hydrogen/deuterium
exchange curves shows that uncoupling is accompanied by the solvent
exposure of previously buried peptide hydrogens [93]. Although the
regions of the nAChR that become solvent-exposed have not been
deﬁned, the critical importance of the ECD/TMD interface in channel
function [40,111] led to the hypothesis that uncoupling results from
structural changes at this interface. Onemodel proposes that weakened
interactions leading to an increased physical separation between the
ECD and TMD accounts for both the loss of function and the increased
solvent accessibility in the uncoupled state [93]. The proposed structur-
al independence of the ECD is supported by a number of crystallograph-
ic studies [30,31,112].
The nAChR structure also shows that the C-terminus of M4 (post-
M4, speciﬁcally Gln435) extends beyond the lipid bilayer to interact
with a conserved residue (Phe137) in the Cys-loop (Fig. 2). Given that
the Cys-loop plays a central role at the interface between the ECD and
TMD, it was postulated that interactions between post-M4 and the
Cys-loop are important for coupling agonist-binding to channel gating
[93]. Considerable functional data support a role for post-M4 in channel
function [113–115]. The M4 lipid-sensor model proposes that lipids
inﬂuenceM4 binding toM1/M3 tomodulate post-M4/Cys-loop interac-
tions and thus channel function. Ineffective post-M4/Cys-loop interac-
tions could lead to partial dissociation of the ECD from the TMD to
form the uncoupled state [93]. Modulatable binding has been discussed
in terms of both the conformational selection and kinetic effects of lipids
on nAChR function (Fig. 4) [61].
4. Prokaryotic pLGICs as models of lipid–nAChR interactions
4.1. Insight from crystal structures of prokaryotic pLGICs
The homologous homopentameric prokaryotic pLGICs, GLIC and
ELIC, are expressed in Escherichia coli at levels sufﬁcient for both
biochemical and structural studies, and each has yielded several high
resolution crystal structures (Fig. 1) [21–23,116–119]. These structures
reveal two key features that impact on our understanding of lipid–
nAChR interactions.
First, the crystal structures of GLIC exhibit electron density located at
the periphery of the TMD, suggesting the presence of partially-ordered
lipid molecules (Fig. 3) [23]. Two of the three lipid binding sites on
each subunit are found at the interfaces between M4 and the adjacent
TMD α-helices M1 and M3. One of these bridges interactions between
post-M4 (F315) and the β6–β7 loop (F121), the loop analogous to the
Cys-loop in eukaryotic pLGICs. Intriguingly, the lipid bridging post-M4
to theβ6–β7 loop in theGLIC structure is displaced slightly by the inhib-
itory anesthetic propofol, suggesting that the lipid occupies an allosteric
site [26]. The ﬁnding that lipids bind to the M4–M1/M3 interface in the
GLIC structure supports the hypothesis that lipids inﬂuenceM4–M1/M3
interactions.
Second, crystal structures of ELIC solved in the presence of agonist
exhibit electron density in the agonist site, but show no structural rear-
rangements in the TMD pore relative to crystal structures solved in the
absence of agonist [118,120,121]. In fact, no movement of the pore-
lining M2 α-helices was detected with mutants that prolong channel
opening and exhibit no propensity to desensitize. It has been suggested
that the ELIC structures reﬂect a conformation that is refractory to ago-
nist binding [121] — i.e., a conformation that is functionally equivalent
to the lipid-dependent uncoupled state of the Torpedo nAChR [122].
Signiﬁcantly, the ELIC structures exhibit multiple proposed features of
the uncoupled nAChR (Figs. 1 and 2): 1) The M4 α-helix is partially
unwound and tilted away from the remaining TMD, with several
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ture, ELIC shows no direct contact between post-M4 and the β6–β7
loop, and 3) the tilting of M4 away from the remainder of the TMD is
accompanied by reduced contact between both the β1–β2 and β6–β7
loops of the ECD and the M2–M3 linker of the TMD. In the nAChR
structure, the extended side chains of the β1–β2 and β6–β7 loops
engage the M2–M3 linker in a fashion reminiscent of vice grips
attached to a metal pipe. In ELIC, the β1–β2 and β6–β7 loops no longer
surround the M2–M3 linker, which itself tilts toward the membrane
surface so that it approaches the β8–β9 loop on the complementary
face of the adjacent subunit. In effect, reduced interactions between
M4 and M1/M3 are accompanied by weakened interactions between
the ECD and TMD— as predicted by the M4 lipid-sensor model.
4.2. Testing the role of M4 in pLGIC lipid-sensing
The noted difference in the position ofM4 in the crystal structures of
ELIC and GLIC is intriguing given the demonstrated importance of
aromatic residues in the binding of M4 to M1/M3 during folding of the
homologous glycine receptor [123]. GLIC has nine aromatic residues at
the interfaces between M4 and M1/M3 that are involved in extensive
π–π interactions (Fig. 5A). These strong interactions likely contribute
to the apparent tight interactions between M4 and M1/M3 in the GLIC
crystal structure. Four of these aromatic residues at the M4–M1/M3
interface are conserved in ELIC. The remaining ﬁve aromatics are
replaced in ELIC by aliphatic residues (Fig. 5B). In particular, ELIC lacks
a cluster of three aromatic residues located near post-M4 that may be
essential in GLIC for effective binding of post-M4 to the remainder of
the TMD and/or the β6–β7 loop. The absence of this post-M4 cluster
in ELIC may lead to the aforementioned tilting of the C-terminus of
M4 away from the main body of the TMD in the crystal structure of
ELIC. The lower number of aromatic interactions at the M4–M1/M3M2
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Fig. 5.Aromatic residues at theM4–M1/M3 interface of A) GLIC andB) ELIC. Top panel: Side view
interface as yellow sticks. Bottom panel: Top view from the extracellular surface of a single TMinterface may render M4 binding to M1/M3 weaker in ELIC and thus
make ELIC more susceptible to the perturbing effects of detergent solu-
bilization during crystallization than GLIC [122].
In light of the above structural differences, aromatic substitutions
were used to test the effects of altered M4–M1/M3 interactions on
pLGIC activity (Carswell et al., revised manuscript under review). Ala
substitutions of aromatic residues were introduced into the M4–M1/
M3 interface of GLIC to weaken M4 binding [123], with every aromatic
substitution leading to reduced channel function. Conversely, aliphatic
to aromatic substitutions were introduced at the same interface in
ELIC to promote M4 binding, with every aromatic addition leading to
enhanced channel function. In fact, the introduction of a single pair of
interacting aromatic residues on the C-terminus of M4 and the
N-terminus of M3 decreased the EC50 for ELIC channel gating almost
10-fold, implying close to a 10-fold potentiation of channel function.
The data support a key tenet of the M4 lipid-sensor model, that
enhanced interactions between M4 and M1/M3 promote coupling
between the agonist binding site and channel gate.
Additional studies suggest that modulatable M4 binding to M1/
M3 plays a role in pLGIC lipid sensing. Protocols for reconstituting
GLIC and ELIC into lipid bilayers have been developed [124–128].
As noted, the extensive aromatic network at the M4–M1/M3 inter-
face in GLIC contributes to relatively strong M4–M1/M3 interactions
along the entire length of M4. In contrast to the nAChR, which
exhibits few aromatic interactions at the M4–M1/M3 interface,
GLIC retains robust agonist-induced gating in the minimal PC mem-
branes that stabilize the uncoupled nAChR [127]. In fact, electro-
physiological measurements suggest that GLIC function is relatively
insensitive to its lipid environment [124,126]. The intrinsic strength
of M4–M1/M3 interactions in GLIC may be sufﬁcient to maintain
effective M4–M1/M3 interactions and retain channel function, even
in PC membranes lacking cholesterol and anionic lipids. In contrast,M2
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M3
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of a single TMD fromboth GLIC and ELIC highlighting aromatic residues at theM4–M1/M3
D.
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the M4–M1/M3 interface in ELIC appear to be sufﬁcient to stabilize
M4–M1/M3 interactions in this region, ELIC does not gate open in
response to agonist in these minimal PC membranes. This lack of
function may be due to the absence of effective post-M4 aromatic
interactions. Signiﬁcantly, engineering the post-M4 aromatic cluster
into ELIC restores the ability of ELIC to gate open in PC bilayers [128].
Modulatable post-M4–M1/M3 interactions thus play a role in ELIC
lipid-sensing.
5. Lipids and the folding and trafﬁcking of nAChRs
The proposed role of M4 binding toM1/M3 in lipid sensingmay also
be relevant to the folding, assembly, and trafﬁcking of nAChRs to the cell
surface. Although many factors are known to inﬂuence mammalian
nAChR trafﬁcking [129–131] (see also [132]), a role for M4 binding to
M1/M3 has been clearly demonstrated in the homologous glycine
receptor. When expressed in oocytes, the glycine receptor is cleaved
within the intracellular loop, but still undergoes agonist-induced chan-
nel gating. A truncated glycine receptor containing both the ectodomain
and the ﬁrst three TMDα-helices fails to trafﬁc to the cell surface [123].
Co-expression with the M4 α-helix, however, rescued both folding and
cell surface expression, with the cell-surface expressed channels indis-
tinguishable from wild type channels in terms of their gating behavior.
Aromatic interactions at the interface between M4 and M1/M3 were
found to be critical forM4 binding and thus in the folding and trafﬁcking
of these pLGICs.
Post-M4 appears to be critical for the surface expression of Torpedo
nAChRs in frog oocytes [113]. Deletion of C-terminal residues from M4
in the homologous GABAρ1 [133] and 5-HT3A [134] receptors also
leads to non-functional channels. In the latter case, elimination of 2 or
more residues prevents trafﬁcking to the cell surface, suggesting that
post-M4 plays an important role in cell surface trafﬁcking of many
pLGICs. M4 binding to M1/M3 in a homomeric α7/5HT3A chimera
locks the chimera in a functional conformation via direct post-M4/
Cys-loop interactions [114].
As noted above, thick membranes support slow agonist-induced
conformational transitions from uncoupled to coupled conformations.
Lipid rafts/microdomains are typically enriched in cholesterol, which
orders and increases the hydrophobic thickness of the bilayer [57,
135]. Both muscle-type and neuronal nAChRs require lipid rafts for
trafﬁcking to the plasmamembrane,with the raft-forming lipids choles-
terol, sphingolipids, and ceramides being important [107,108,136–138].
Disruption of these rafts leads to both altered cell surface exposure
and altered nAChR function [138,139]. Integral membrane proteins
with shorter transmembrane α-helices tend to remain in intracellular
membrane compartments, possibly because they hydrophobically
match the thinner intracellular membranes more favorably [57,140].
Partitioning of the nAChR into thicker lipid rafts could favor transitions
from uncoupled to coupled conformations, as we observe in the thicker
di22:1PC model membranes. If this transition leads to a preferential
alignment of M4 perpendicular to themembrane surface, the increased
hydrophobic length ofM4 should promote trafﬁcking to the cell surface.
Such a mechanism could explain why nicotine acts as a chaperone to
promote cell-surface expression of the high afﬁnity (α4)2(β2)3 nAChR
versus the lower afﬁnity (α4)3(β2)2 nAChR [141]. Preferential nicotine
binding could lead tomaturation of the high afﬁnity (α4)2(β2)3 nAChRs
toward coupled (resting or desensitized) conformations where M4 is
aligned closer to the bilayer normal to promote cell-surface expression.
In this scenario, limited binding would thus have minimal effect on the
trafﬁcking of the low afﬁnity (α4)3(β2)2 nAChR.
6. Role of lipids in the clustering of nAChRs in the plasmamembrane
Both the clustering of nAChRs on the plasma membrane and the
internalization of cytoplasmic membrane-located nAChRs are lipidraft-dependent [142]. Lowering cholesterol levels to disrupt lipid rafts
leads to altered nAChR clustering andmobility on cell surfaces, rapid in-
ternalization, and ultimately enhances function of the surface-retained
nAChRs [139,143,144].
Although the molecular mechanisms underlying nAChR lipid-raft
associations remain obscure, it has been shown that incorporation of
the nAChR into model membranes containing anionic lipids, particular-
ly PA, leads to a change in the packing properties of the surrounding
bilayer [55,145]. The nAChR concentrates cations, including protons, at
the bilayer surface, facilitating the ordering of nearby anionic lipids
[56,146]. There appear to be favorable interactions between the
nAChR and ordered lipids, such as those found in lipid rafts.
Another intriguing observation is that afﬁnity-puriﬁed and detergent-
solubilized Torpedo nAChR exhibits a PA-speciﬁc phospholipase C activi-
ty [54]. The hydrolysis product of PA, diacylglycerol, is a potent nAChR
activator [54]. A nAChR-associated phospholipase activity could allow
the nAChR itself to alter its own lipid micro-environment, which could
have two effects. In the context of a lipid raft-associated receptor,
nAChR-induced changes in the lipid micro-environment could lead to
relatively long term changes in nAChR activity and thus synaptic strength.
Secondly, PA hydrolysis would reduce the number of negatively charged
PA head groups in the nAChR micro-environment. Given the nAChR's
ability to concentrate cations and interact preferentially with negative
lipids, particularly PA, a loss of PA could create less favorable interactions
between the nAChR and its surrounding lipids,whichmay ultimately lead
to nAChR trafﬁcking from a less favorable to more favorable lipid micro-
environments.While the existence of this phospholipase activity in native
membranes and its relation to nAChR activity in vivo both remain to be
deﬁned, these speculative hypotheses highlight the fact that we are just
beginning to understand the complexities underlying nAChR–lipid inter-
actions and the potential importance of these interactions in vivo.
7. Conclusions
Three decades of research have revealed both an exquisite sensitiv-
ity of the Torpedo nAChR to its surrounding lipid environment and a
tremendous complexity to lipid–nAChR interactions. While many lipids
likely inﬂuence function, cholesterol and anionic lipids play a vital role
in stabilizing the nAChR in a functional conformation. Membrane phys-
ical properties also play a poorly understood role. Recent research has
shown that even trace lipids found in complex membrane environ-
ments can impact on nAChR function. Considerable research is still
required to fully understand how different lipids inﬂuence nAChR func-
tion in a biological context.
Lipids/membranes inﬂuence the nAChR by both conformational
selection and kinetic mechanisms. Different lipids/membranes stabi-
lize varying proportions of pre-existing resting, open, desensitized,
and uncoupled conformations, as well as inﬂuence the transitions
between these conformational states. Although the mechanisms
by which lipids/membranes interact preferentially with these differ-
ent conformations/transition states to inﬂuence function remain
obscure, increasing evidence points to a role for the outermost trans-
membrane α-helix in lipid sensing. Both lipid binding and bulk
membrane effects likely inﬂuence M4 interactions with M1/M3 to
alter function. One hypothesis is that lipid-sensitive interactions
between M4 with M1/M3 ultimately inﬂuence interactions between
post-M4 and the Cys-loop to regulate nAChR activity; although this
still hypothesis requires rigorous testing.
A lipid-dependent uncoupled conformation has been identiﬁed that
may form as a result of an M4-dependent loss of physical contact be-
tween the ECD and the TMD. While this conformation has only been
conclusively demonstrated for Torpedo nAChRs in reconstituted mem-
branes, it may also exist for other pLGICs. Functionally equivalent con-
formations have been detected with neuronal nAChRs, and with the
detergent-solubilized prokaryotic pLGIC, ELIC. An important goal will
be to test for existence of uncoupled nAChRs in biological membranes,
1815J.E. Baenziger et al. / Biochimica et Biophysica Acta 1848 (2015) 1806–1817and whether lipids or other allosteric modulators enhance the tran-
sition from uncoupled to coupled conformations to enhance synaptic
communication.
There is considerable interest in the role of nAChRs in neurodegener-
ative diseases, such as Alzheimer's disease, Parkinson's disease, as well
as in other neurological disorders, such as epilepsy and schizophrenia.
The role of lipid–nAChR interactions in disease progression remains to
be studied. Altered lipid proﬁles leading to altered lipid–nAChR interac-
tions could lead to altered cholinergic activity, with small functional
changes resulting in severe physiological effects. Fundamental knowl-
edge of how different neuronal nAChRs respond to changes in their
lipid environmentsmay prove important for understanding themecha-
nisms of altered cholinergic activity during the course of humandisease.
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